These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9253810)

  • 21. Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin.
    Jakubowski JA; Maraganore JM
    Blood; 1990 Jan; 75(2):399-406. PubMed ID: 2294999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of recombinant hirudin on various platelet functions.
    Basic-Micic M; Rauschenbach C; Breddin HK
    Haemostasis; 1991; 21 Suppl 1():107-15. PubMed ID: 1894185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anesthetics and anticoagulants used in the preparation of rat platelet-rich-plasma alter rat platelet aggregation.
    Dwyer SD; Meyers KM
    Thromb Res; 1986 Apr; 42(2):139-51. PubMed ID: 3087006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet function testing in hirudin and BAPA anticoagulated blood.
    Mani H; Hellis M; Lindhoff-Last E
    Clin Chem Lab Med; 2011 Mar; 49(3):501-7. PubMed ID: 21175382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant hirudin as an anticoagulant during cardiac operations: experiments in a pig model.
    Riess FC; Pötzsch B; Behr I; Jäger K; Rössing R; Bleese N; Schaper W; Müller-Berghaus G
    Eur J Cardiothorac Surg; 1997 Apr; 11(4):739-45. PubMed ID: 9151047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I at arterial flow conditions in a porcine model: effects of hirudins, heparin, and calcium chelation.
    Badimon L; Badimon JJ; Lassila R; Heras M; Chesebro JH; Fuster V
    Blood; 1991 Jul; 78(2):423-34. PubMed ID: 2070078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Future alternatives to heparin: low-molecular-weight heparin and hirudin.
    Donayre CE; Ouriel K; Rhee RY; Shortell CK
    J Vasc Surg; 1992 Apr; 15(4):675-82. PubMed ID: 1313932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of platelet aggregation in ovine blood using a new impedance aggregometer.
    Baumgarten A; Wilhelmi M; Kalbantner K; Ganter M; Mischke R
    Vet Clin Pathol; 2010 Jun; 39(2):149-56. PubMed ID: 20003029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on platelet functions in hirudin plasma.
    Glusa E; Urban U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):88-93. PubMed ID: 2459038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reference range determination for whole-blood platelet aggregation using the Multiplate analyzer.
    Peerschke EI; Castellone DD; Stroobants AK; Francis J
    Am J Clin Pathol; 2014 Nov; 142(5):647-56. PubMed ID: 25319980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of heparin and hirudin on thrombin generation and platelet aggregation after intrinsic activation of platelet rich plasma.
    Gallistl S; Muntean W; Leis HJ
    Thromb Haemost; 1995 Oct; 74(4):1163-8. PubMed ID: 8560429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of blood cell activation by four commonly used anticoagulants.
    Engstad CS; Gutteberg TJ; Osterud B
    Thromb Haemost; 1997 Apr; 77(4):690-6. PubMed ID: 9134644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of ticlopidine and indobufen on platelet aggregation induced by A23187 and adrenaline in the presence of different anticoagulants.
    Cimminiello C; Milani M; Uberti T; Arpaia G; Bonfardeci G
    J Int Med Res; 1989; 17(6):514-20. PubMed ID: 2516825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of unfractionated and low molecular weight heparin on platelet-induced thrombin formation time and platelet adhesion.
    Basic-Micic M; Breddin HK
    Semin Thromb Hemost; 1993; 19 Suppl 1():22-8. PubMed ID: 8395725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EV-077 in vitro inhibits platelet aggregation in type-2 diabetics on aspirin.
    Sakariassen KS; Femia EA; Daray FM; Podda GM; Razzari C; Pugliano M; Errasti AE; Armesto AR; Nowak W; Alberts P; Meyer JP; Sorensen AS; Cattaneo M; Rothlin RP
    Thromb Res; 2012 Nov; 130(5):746-52. PubMed ID: 22959706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sampling conditions influence multiple electrode platelet aggregometry in cardiac surgery patients.
    Karlsson M; Roman-Emanuel C; Thimour-Bergström L; Hakimi CS; Jeppsson A
    Scand Cardiovasc J; 2013 Apr; 47(2):98-103. PubMed ID: 23098207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenaline-induced reactions of human platelets in hirudin plasma.
    Glusa E; Markwardt F
    Haemostasis; 1980; 9(3):188-92. PubMed ID: 7372203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [ON THE ISSUE OF SELECTION OF COAGULANTS UNDER ADP-INDUCED IMPEDANCE TEST OF AGGREGATION OF THROMBOCYTES IN PATIENTS WITH CHRONIC MYELO-PROLIFERATIVE TUMORS].
    Stolyar MA; Ivashin DS; Olkhovsky IA
    Klin Lab Diagn; 2017 Mar; 62(3):156-60. PubMed ID: 30620525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different anticoagulants and platelet reactivity in cardiac surgical patients.
    John LC; Rees GM; Kovacs IB
    Ann Thorac Surg; 1993 Oct; 56(4):899-902. PubMed ID: 8215666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.